Natalie Oehlers, associate in the firm's FDA & Biotechnology practice group, was quoted in an Inside Health Policy article entitled "2023: Telenursing, Integrated Telehealth Programs, AI In Spotlight."
We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.
Already a subscriber and want to update your preferences? Click here.